OpenLegislation

Division 6 The following particulars shall appear on the immediate and the outer packaging:

United Kingdom

Original text. Later amendments are not shown.

  1. (a)

    name of the main contact;

  2. (b)

    name of the medicinal product, followed by its strength and pharmaceutical form;

  3. (c)

    statement of the active substances expressed qualitatively and quantitatively per dosage unit;

  4. (d)

    batch or code number identifying the contents and packaging operation;

  5. (e)

    clinical trial reference code allowing identification of the clinical trial site, investigator and subject;

  6. (f)

    directions for use (reference may be made to a leaflet or other explanatory document intended for the subject or person administering the product);

  7. (g)

    ’For clinical trial use only’ or similar wording;

  8. (h)

    the storage conditions; and

  9. (i)

    period of use (expiry date or retest date as applicable).